Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company based in Boulder, CO, specializing in the development of precision medicines for rare muscle disorders. With a focus on muscular dystrophies and hypertrophic cardiomyopathy, their innovative approach aims to protect and improve muscle health, ultimately enhancing the lives of individuals living with progressive muscle diseases.
Driven by a commitment to patients and their families, Edgewise Therapeutics leverages their deep understanding of integrated muscle physiology to develop novel therapies that address significant unmet medical needs. Through their proprietary drug discovery platform, they are dedicated to transforming muscle research and advancing the field of precision medicine for severe and rare muscle disorders.
Generated from the website